BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Delmas D. Silymarin and Derivatives: From Biosynthesis to Health Benefits. Molecules 2020;25:E2415. [PMID: 32455869 DOI: 10.3390/molecules25102415] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Koltai T, Fliegel L. Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions. J Evid Based Integr Med 2022;27:2515690X211068826. [PMID: 35018864 DOI: 10.1177/2515690X211068826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Basu A, Bhowmick S, Mukherjee A. Flavonolignan silibinin abrogates SDS induced fibrillation of human serum albumin. Journal of the Indian Chemical Society 2022;99:100275. [DOI: 10.1016/j.jics.2021.100275] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jahanian E, Mahdavi A, Jahanian R. Silymarin improved the growth performance via modulating the microbiota and mucosal immunity in Escherichia coli-challenged broiler chicks. Livestock Science 2021;249:104529. [DOI: 10.1016/j.livsci.2021.104529] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Palit P, Mukhopadhyay A, Chattopadhyay D. Phyto-pharmacological perspective of Silymarin: A potential prophylactic or therapeutic agent for COVID-19, based on its promising immunomodulatory, anti-coagulant and anti-viral property. Phytother Res 2021;35:4246-57. [PMID: 33817867 DOI: 10.1002/ptr.7084] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
5 Vilahur G, Sutelman P, Mendieta G, Ben-Aicha S, Borrell-Pages M, Peña E, Crespo J, Casaní L, Badimon L. Triglyceride-induced cardiac lipotoxicity is mitigated by Silybum marianum. Atherosclerosis 2021;324:91-101. [PMID: 33857761 DOI: 10.1016/j.atherosclerosis.2021.03.014] [Reference Citation Analysis]
6 Ignat MV, Coldea TE, Salanță LC, Mudura E. Plants of the Spontaneous Flora with Beneficial Action in the Management of Diabetes, Hepatic Disorders, and Cardiovascular Disease. Plants (Basel) 2021;10:216. [PMID: 33498684 DOI: 10.3390/plants10020216] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
7 Beyoğlu D, Idle JR. Metabolomic insights into the mode of action of natural products in the treatment of liver disease. Biochemical Pharmacology 2020;180:114171. [DOI: 10.1016/j.bcp.2020.114171] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]